Halozyme is a biopharmaceutical company dedicated to improving patient experiences and outcomes through disruptive solutions. By leveraging our proprietary ENHANZE® technology, which reduces treatment times from hours to mere minutes, we have positively impacted over 400,000 patient lives across 100...See more
Headquarter United States of America |
Funding status Publicly listed on stock exchange |
Company type MNC / Large Enterprise |
Founder
Company Owner
trch